Brief: Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
11/05/2023 21:41
May 11 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* ETON PHARMACEUTICALS INC - QTRLY PRODUCT SALES AND ROYALTY
REVENUE OF $5.3 MILLION UP 144% FROM Q1 2022 AND 52% FROM Q4
2022
* ETON PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nGNX1zlW5Z
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer